Oncolytic Urabe mumps virus: A promising virotherapy for triple-negative breast cancer

Authors: Behrens, Marshall D., Stiles, Robert J., Pike, Gennett M., Sikkink, Laura A., Zhuang, Yongxian, Yu, Jia, Wang, Liewei, Boughey, Judy C., Goetz, Matthew P., Federspiel, Mark J.

Source: In Molecular Therapy - Oncolytics 15 December 2022 27:239-255

Preclinical safety assessment of MV-s-NAP, a novel oncolytic measles virus strain armed with an H. pylori immunostimulatory bacterial transgene

Authors: Viker, Kimberly B., Steele, Michael B., Iankov, Ianko D., Concilio, Susanna C., Ammayappan, Arun, Bolon, Brad, Jenks, Nathan J., Goetz, Matthew P., Panagioti, Eleni, Federspiel, Mark J., Liu, Minetta C., Peng, Kah Whye, Galanis, Evanthia

Source: In Molecular Therapy - Methods & Clinical Development 8 September 2022 26:532-546

Live Attenuated Measles Virus Vaccine Expressing Helicobacter pylori Heat Shock Protein A

Authors: Iankov, Ianko D., Kurokawa, Cheyne, Viker, Kimberly, Robinson, Steven I., Ammayappan, Arun, Panagioti, Eleni, Federspiel, Mark J., Galanis, Evanthia

Source: In Molecular Therapy - Oncolytics 16 December 2020 19:136-148

Oncolytic Measles Virotherapy and Opposition to Measles Vaccination

Authors: Russell, Stephen J., Babovic-Vuksanovic, Dusica, Bexon, Alice, Cattaneo, Roberto, Dingli, David, Dispenzieri, Angela, Deyle, David R., Federspiel, Mark J., Fielding, Adele, Galanis, Eva, Lacy, Martha Q., Leibovich, Bradley C., Liu, Minetta C., Muñoz-Alía, Miguel, Miest, Tanner C., Molina, Julian R., Mueller, Sabine, Okuno, Scott H., Packiriswamy, Nandakumar, Peikert, Tobias, Raffel, Corey, Van Rhee, Frits, Ungerechts, Guy, Young, Paul R., Zhou, Yumei, Peng, Kah-Whye

Source: In Mayo Clinic Proceedings September 2019 94(9):1834-1839

Dissection of the c-Kit Signaling Pathway in Mouse Primordial Germ Cells by Retroviral-Mediated Gene Transfer

Authors: De Miguel, Maria P., Cheng, Linzhao, Holland, Eric C., Federspiel, Mark J., Donovan, Peter J.

Source: Proceedings of the National Academy of Sciences of the United States of America, 2002 Aug 01. 99(16), 10458-10463.

Access URL: https://www.jstor.org/stable/3059412

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Authors: Msaouel, Pavlos, Opyrchal, Mateusz, Dispenzieri, Angela, Peng, Kah Whye, Federspiel, Mark J., Russell, Stephen J., Galanis, Evanthia

Source: Current cancer drug targets. 18(2):177-187

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100078024808.0x000001&indx=1&recIds=ETOCvdc_100078024808.0x000001

Expression of Transduced Genes in Mice Generated by Infecting Blastocysts with Avian Leukosis Virus-Based Retroviral Vectors

Authors: Federspiel, Mark J., Swing, Deborah A., Eagleson, Bryn, Reid, Susan W., Hughes, Stephen H.

Source: Proceedings of the National Academy of Sciences of the United States of America, 1996 May . 93(10), 4931-4936.

Access URL: https://www.jstor.org/stable/38879

Robust Oncolytic Virotherapy Induces Tumor Lysis Syndrome and Associated Toxicities in the MPC-11 Plasmacytoma Model

Authors: Zhang, Lianwen, Steele, Michael B, Jenks, Nathan, Grell, Jacquelyn, Behrens, Marshall, Nace, Rebecca, Naik, Shruthi, Federspiel, Mark J, Russell, Stephen J, Peng, Kah-Whye

Source: In Molecular Therapy December 2016 24(12):2109-2117

Recombinant mumps virus as a cancer therapeutic agent

Authors: Ammayappan, Arun, Russell, Stephen J, Federspiel, Mark J

Source: In Molecular Therapy - Oncolytics 2016 3

Efficient method to optimize antibodies using avian leukosis virus display and eukaryotic cells

Authors: Yu, Changming, Pike, Gennett M., Rinkoski, Tommy A., Correia, Cristina, Kaufmann, Scott H., Federspiel, Mark J.

Source: Proceedings of the National Academy of Sciences of the United States of America, 2015 Aug 01. 112(32), 9860-9865.

Access URL: https://www.jstor.org/stable/26464789

Measles Vaccine Strains for Virotherapy of Non–Small-Cell Lung Carcinoma

Authors: Patel, Manish R., Jacobson, Blake A., Belgum, Holly, Raza, Ahmad, Sadiq, Ahad, Drees, Jeremy, Wang, Hengbing, Jay-Dixon, Joseph, Etchison, Ryan, Federspiel, Mark J., Russell, Stephen J., Kratzke, Robert A.

Source: In Journal of Thoracic Oncology August 2014 9(8):1101-1110

Remission of Disseminated Cancer After Systemic Oncolytic Virotherapy

Authors: Russell, Stephen J., Federspiel, Mark J., Peng, Kah-Whye, Tong, Caili, Dingli, David, Morice, William G., Lowe, Val, O'Connor, Michael K., Kyle, Robert A., Leung, Nelson, Buadi, Francis K., Rajkumar, S. Vincent, Gertz, Morie A., Lacy, Martha Q., Dispenzieri, Angela

Source: In Mayo Clinic Proceedings July 2014 89(7):926-933

Oncolytic measles and vesicular stomatitis virotherapy for endometrial cancer

Authors: Liu, Yu-Ping, Steele, Michael B., Suksanpaisan, Lukkana, Federspiel, Mark J., Russell, Stephen J., Peng, Kah Whye, Bakkum-Gamez, Jamie N.

Source: In Gynecologic Oncology January 2014 132(1):194-202

Carcinoembryonic antigen-expressing oncolytic measles virus derivative in recurrent glioblastoma: a phase 1 trial.

Authors: Galanis, Evanthia, Dooley, Katharine E., Keith Anderson, S., Kurokawa, Cheyne B., Carrero, Xiomara W., Uhm, Joon H., Federspiel, Mark J., Leontovich, Alexey A., Aderca, Ileana, Viker, Kimberly B., Hammack, Julie E., Marks, Randolph S., Robinson, Steven I., Johnson, Derek R., Kaufmann, Timothy J., Buckner, Jan C., Lachance, Daniel H., Burns, Terry C., Giannini, Caterina, Raghunathan, Aditya

Source: Nature Communications; 1/12/2024, Vol. 15 Issue 1, p1-12, 12p

Subject Terms: MEASLES virus, CARCINOEMBRYONIC antigen, GLIOBLASTOMA multiforme, CLASSIFICATION algorithms, ANTINEOPLASTIC agents, VIRAL replication

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in uveal melanoma: safety, efficacy, and T cell responses.

Authors: Smith, Katherine E. R., Kah-Whye Peng, Pulido, Jose S., Weisbrod, Adam J., Strand, Carrie A., Allred, Jacob B., Newsom, Alysha N., Lianwen Zhang, Packiriswamy, Nandakumar, Kottke, Timothy, Tonne, Jason M., Moore, Madelyn, Montane, Heather N., Kottschade, Lisa A., McWilliams, Robert R., Dudek, Arkadiusz Z., Yiyi Yan, Dimou, Anastasios, Markovic, Svetomir N., Federspiel, Mark J.

Source: Frontiers in Immunology; 2023, p1-11, 11p

Subject Terms: UVEA cancer, VESICULAR stomatitis, T cells, PHENOL oxidase, CYTOKINE release syndrome, IMMUNE checkpoint inhibitors

Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth

Authors: Ong, Hooi-Tin, Federspiel, Mark J., Guo, Chang M., Ooi, London Lucien, Russell, Stephen J., Peng, Kah-Whye, Hui, Kam M.

Source: In Journal of Hepatology November 2013 59(5):999-1006

Measles virus expressed Helicobacter pylori neutrophil-activating protein significantly enhances the immunogenicity of poor immunogens

Authors: Iankov, Ianko D., Federspiel, Mark J., Galanis, Evanthia

Source: In Vaccine 1 October 2013 31(42):4795-4801

Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition

Authors: Touchefeu, Yann, Khan, Aadil A., Borst, Gerben, Zaidi, Shane H., McLaughlin, Martin, Roulstone, Victoria, Mansfield, David, Kyula, Joan, Pencavel, Tim, Karapanagiotou, Eleni M., Clayton, Jamie, Federspiel, Mark J., Russell, Steve J., Garrett, Michelle, Collins, Ian, Harrington, Kevin J.

Source: In Radiotherapy and Oncology July 2013 108(1):24-31

Neutralization capacity of measles virus H protein specific IgG determines the balance between antibody-enhanced infectivity and protection in microglial cells

Authors: Iankov, Ianko D., Penheiter, Alan R., Griesmann, Guy E., Carlson, Stephanie K., Federspiel, Mark J., Galanis, Evanthia

Source: In Virus Research March 2013 172(1-2):15-23

Expression of Immunomodulatory Neutrophil-activating Protein of Helicobacter pylori Enhances the Antitumor Activity of Oncolytic Measles Virus

Authors: Iankov, Ianko D, Allen, Cory, Federspiel, Mark J, Myers, Rae M, Peng, Kah Whye, Ingle, James N, Russell, Stephen J, Galanis, Evanthia

Source: In Molecular Therapy June 2012 20(6):1139-1147